Smokeless tobacco brand switching: A means to reduce toxicant exposure?

被引:20
作者
Hatsukami, D. K.
Ebbert, J. O.
Anderson, A.
Lin, H.
Le, C.
Hecht, S. S.
机构
[1] Univ Minnesota, Tobacco Use Res Ctr, Minneapolis, MN 55414 USA
[2] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA
[3] Mayo Clin, Coll Med, Rochester, MN 55905 USA
关键词
smokeless tobacco; brand switching; toxicant exposure; tobacco use cessation;
D O I
10.1016/j.drugalcdep.2006.08.021
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The purpose of this study was to examine the effects of smokeless tobacco (ST) brand switching on biomarkers of ST exposure and on ST use. Subjects seeking treatment to reduce their use were randomized to ST brand switching with controlled ST topography, brand switching with ad libitum ST use, or a waitlist control with subsequent randomization to one of these two conditions. The waitlist control group was included to assess whether changes were a consequence of time effect. During the intervention, Copenhagen or Kodiak ST users were asked to switch to products that were sequentially lower in nicotine content: Skoal Long Cut Straight or Wintergreen for 4 weeks and then Skoal Bandits for the subsequent 4 weeks. Measures were obtained during the course of treatment and at 12-week follow-up. Significant reductions in total urinary cotinine and 4-(methylnitrosamino)-L-(3-pyridyl)-L-butanol (NNAL) plus its glucuronides (total NNAL) were observed with no significant differences between the controlled topography and ad libitum conditions. Significant reductions were also observed in the amount and duration of dips with a significant intervention effect for durational measures. At 12 weeks, the 7-day biochemically-verified tobacco abstinent rate was 26% in the ad libitum group. ST brand switching may be a feasible alternative intervention for ST users interested in quitting but unwilling to Stop ST use completely. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 46 条
[1]   THE CONTEMPLATION LADDER - VALIDATION OF A MEASURE OF READINESS TO CONSIDER SMOKING CESSATION [J].
BIENER, L ;
ABRAMS, DB .
HEALTH PSYCHOLOGY, 1991, 10 (05) :360-365
[2]   Smokeless tobacco use and risk of cancer of the pancreas and other organs [J].
Boffetta, P ;
Aagnes, B ;
Weiderpass, E ;
Andersen, A .
INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (06) :992-995
[3]   MEASURING DEPENDENCE IN SMOKELESS TOBACCO USERS [J].
BOYLE, RG ;
JENSEN, J ;
HATSUKAMI, DK ;
SEVERSON, HH .
ADDICTIVE BEHAVIORS, 1995, 20 (04) :443-450
[4]  
BRUNNEMANN KD, 2001, AGING ORAL MOIST STU
[5]  
Carmella SG, 2003, CANCER EPIDEM BIOMAR, V12, P1257
[6]  
Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P398
[7]  
Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO
[8]  
2-E
[9]   Smokers' knowledge and understanding of advertised tar numbers: Health policy implications [J].
Cohen, JB .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (01) :18-24
[10]  
Dale Lowell C, 2002, Nicotine Tob Res, V4, P267, DOI 10.1080/14622200210153821